According to Habil F Khorakiwala, India is becoming a research and manufacturing hub for global pharmaceutical generic companies and the Indian companies that have well established base in the generic space like Stride transaction are getting high valuation.
first published: Dec 24, 2013 02:08 pm
A collection of the most-viewed Moneycontrol videos.
Nifty Sees Triple-Digit Cut Despite Strong Q2 From SBI & M&M; All Sectors In Red | Closing Bell Live
Groww's Rs 6,632 Cr IPO Opens For Subscription | Management On Future Path | IPO Watch Live
Realty, PSU Banks Lead Nifty Back Near 25,800; Shriram Finance Scales Record High| Closing Bell Live
Will D-Street See A Sweet Start To November? Autos In Focus After Record Sales| Opening Bell Live
